Announcing Distinguished Speakers for WuXi Healthcare Forum 2019


WuXi Healthcare Forum 2019

Inspired by Meeting Tomorrow’s Health Challenges

March 5-6, 2019 | St. Regis Shanghai

Registration and full agenda, please click here.

We are at the dawn of a new age in healthcare, with global R&D potentially on the brink of transformational productivity improvements, with innovators coming from ever more diverse backgrounds, and with independent global markets becoming ever increasingly connected.

Inspired by harnessing our collective wisdom to break down silos and act boldly on new thinking, more than 2,000 global leaders will gather in Shanghai on March 5-6 to participate in the inaugural WuXi Healthcare Forum 2019. This invitation-only event will challenge us to explore what breakthroughs have been achieved, the present realities and future possibilities. Spanning two unique days, the agenda will traverse the current universe from genomics to ‘glocal’ R&D, from cancer treatments to the hard economics of paying for hospital care and, of course, new therapies. It’s about widening the lens and seeing the technologies and scopes needed to improve health.

Confirmed Speakers:
(order by sessions)
March 5, 9am – 5pm
Ge Li, Chairman, WuXi AppTec Group
Ruilin Song, Executive President, China Pharmaceutical Innovation and Research Development Association
Steve Bates, CEO, UK BioIndustry Association
Leon Wang, Executive Vice President, International and China President of AstraZeneca
Edward Hu, Co-CEO, WuXi AppTec
Kevin Holland, Minister-Counsellor and Director of Life Sciences, Healthcare and Social Care for China, British Embassy Beijing
Yongjun Liu, Global Head of Research, Sanofi
Lianshan Zhang, President, Global R&D, Jiangsu Hengrui Medicine Co.
George Chen, Sr. VP, Global R&D Oncology Unit; Head, R&D China, AstraZeneca
Harald Reinhart, Chief Medical Officer, Autoimmune & Infectious Diseases, Zai Laboratory, Zai Lab
Damian O’Connell, CEO, Experimental Drug Development Centre, A*STAR
Steve Yang, EVP, CBO, WuXi AppTec
David Ho, Scientific Director and CEO, Aaron Diamond AIDS Research Center
Zhijian “James” Chen, George L. MacGregor Distinguished Chair in Biomedical Science, UT Southwestern Medical Center
Ram Sasisekharan, the Alfred H. Caspary Professor of Biological Engineering,Massachusetts Institute of Technology
Jane Osbourn, Vice President R&D, MedImmune, Chair UK BioIndustry Association
John Oyler, Chairman, Co-Founder & CEO, BeiGene
Michael Yi, Partner, Hillhouse Capital Group
Nisa Leung, Managing Partner, Qiming Venture Partners
Ken Drazan, Co-founder and CEO, Arsenal Bio
Ruyi He, Chief Scientific Officer, SDIC Fund Management
Michael Yi Yao, Co-Chairman, Gem Flower Pharma Tech
Gang Wang, Vice President for Quality and Global Regulatory Affairs, WuXi Biologics
Chiang Syin, Chief Quality Officer, WuXi Biologics
Craig Anderson, Professor, University of New South Wales in Sydney; Executive Director, The George Institute for Global Health China
Zhengqing Li, VP and Head of China Development, MSD
Matt Cooper, Exec Director – Business Development & Marketing, National Institute for Health Research, UK
Carl Firth, CEO, ASLAN Pharmaceuticals
Jinzi J. Wu, Founder, Chairman and CEO, Ascletis Pharma
James Xue, Chairman and CEO, CANbridge
Alex Zhavoronkov, Founder and CEO, Insilico Medicine
Eric Morgen, COO and CMO, BIOAGE
Karen Reeves, President and CMO, AZTherapies
Sang Hoon Lee, Founder and CEO, ABL Bio
Zhenyu Ju, Dean, Institute of Aging and Regenerative Medicine, Jinan University
Guy Spigelman, VP Portfolio Success, aMoon Fund
Ash Bahl, CSO and Head of R&D, Carrick Therapeutics
Binhe Xu, Director of the Department of Medical Oncology at the National Cancer Center, China
Zhengying Pan, Research Fellow, School of Chemical Biology & Biotechnology,Peking University
Simone Botti, CEO, MetaboMed
Sofie Qiao, President and CEO, Vivace Therapeutics
Darren Ji, Co-founder and CEO, Elpiscience; Venture Partner, Lilly Asia Ventures
Yanni Lin, Chief Technology Officer, CureGenetics
Jörg Weiser, Managing Director, Schrodinger
Misti Ushio, CEO, TARA Biosystem
Qi Liu, Professor, Bioinformatics Department in Tongji University
Naheed Kurji, President and CEO, Cyclica
March 6, 9am – 5pm
Daniel Auerbach, Senior Managing Partner, Eight Roads
William Keller, Chairman, Coland Pharmaceuticals
Li Chen, CEO, Hua Medicine
Chris Chen, CEO, WuXi Biologics
Greg Scott, Founder and CEO, ChinaBio
Dan Wang, Head of Johnson & Johnson Innovation, Asia Pacific
Curtis Keith, CSO, Blavatnik Biomedical Accelerator, Harvard University
Robert S. Sullivan, Dean, Rady School of Management, UC San Diego
Toshio Fujimoto, General Manager, Takeda Shonan Innovation Park, Takeda
Sophie Sun, Managing Director, Merck Innovation Hub China
David Flores, Co-Founder, President and CEO, BioCentury
Ken Hitchner, Chairman and CEO, Asia Pacific Ex-Japan, Goldman Sachs
Yibing Wu, Joint Head, Enterprise Development Group & Head, China, Temasek
Andy Lin, Founding Partner, Loyal Valley Capital
Lee Ligang Zhang, Founder, Chairman and CEO, iKang Healthcare Group
Leon Chen, CEO & Founding Partner, 6 Dimensions Capital
Shuyang Zhang, Vice President, Peking Union Medical College Hospital; Vice President, Chinese Academy of Medical Sciences & Peking Union Medical College
Jiangnan Cai, Director, CEIBS Centre for Health Care Management and Policy
Feng Deng, Founding Managing Director, Northern Light Venture Capital
Rong Yu, Chairman, Meinian Onehealth Healthcare Group; Chairman, Tianyi
Investment Group
Bin Li, Partner and Managing Director, Ally Bridge Group
Guang Ning, Vice President, Ruijin Hospital of Shanghai Jiaotong University
Chunpeng Hao, Deputy Secretary-General, China Health Insurance Research Association
Wei Zhang, Chief Strategy Officer, WuXi AppTec
Wenhao Zhou, VP, Children’s Hospital of Fudan University
Gang Chen, CEO, WeGene
Shaokun Chuai, COO, Burning Rock Dx
Kai Wang, Founder and CEO, OrigiMed
Sijia Lu, CEO, Yikon Genomics
William Morice, President, Mayo Clinic Laboratories
Daozhi Liu, Founding Partner, Sunland Capital
Martien van Osch, Managing Partner, Forbion
Yaoyi Zhu, Chairman, IVD Branch, China Association for Medical Devices Industry
Jason Liu, CEO, WuXi Diagnostics
Tony Zhang, Founder and CEO, LinkDoc Technology
Andy Liu, CEO, CW Data Technologies
Choo Chiap Chiau, AI Lab Director, Philips Research Asia
Hong Li, Vice President, Digital China Health Technologies
Meng Zhang, General Manager, Tencent Health
Ning Hou, COO, XiKang
Xiaodong Tao, Vice President of iFlytek; CEO of iFlytek Healthcare
Fay Xing, CEO, PICA Health
Xinxin Gao, CEO and Founding Partner, JiangmenThese candid conversations, on controversial issues, are essential in transforming today’s many healthcare challenges into tomorrow’s new opportunities. You are welcome to join the conversations.

Please RSVP online, or email if you have any questions.

Subscribe to WXPress

Receive our newsletter and information on upcoming events.